[topsearch__bar__shortcode]

December 3, 2020

BLNK Stock

Waddell & Reed Financial (WDR) stock rocketed in the After hours with the news of takeover

Shares of Waddell & Reed Financial Inc. spiked enormously 48.44% in AH trading to $25.25 after a slight surge of 0.83% during the regular session in the previous close, following the news of a $1.7 billion deal has been signed by Macquarie Group Ltd. to takeover Waddell & Reed Financial Inc. inline to broaden its […]

Waddell & Reed Financial (WDR) stock rocketed in the After hours with the news of takeover Read More »

CTEK Stock

Macquarie Global Infrastructure Total Return Fund (NYSE:MGU) stock stumbled in the late-hours after this Update

Macquarie Global Infrastructure Total Return Fund (NYSE: MGU) stock tumbled -0.67% to $20.50 in the after-market after the company Board of Directors approved a daily payout of $0.075 per share for the month ending Nov. 30, 2020. The $0.075 per share payout is equivalent to an annualized distribution rate of 3.73 percent at NAV and

Macquarie Global Infrastructure Total Return Fund (NYSE:MGU) stock stumbled in the late-hours after this Update Read More »

SMAR Stock

Ever Glory Intl Group. (EVK) stock mounted in the after-market

As in the morning, another round of large movers began the evening. For some people, the surprise is that no news or catalysts have been reported as Ever Glory Intl Group. (EVK) shares surged 78.57% to $3.75 in the after-market. However, on November 12, 2020, the Company posted its Q3 earnings. EVK’s gross sales were

Ever Glory Intl Group. (EVK) stock mounted in the after-market Read More »

AUPH Stock

Iterum Therapeutics plc (Nasdaq: ITRM) saw big hike in after-market with the news of New Drug Proposal to FDA

Iterum Therapeutics plc (Nasdaq: ITRM) shares surged 39.31% to $0.9055 in the after-hours session, after a drug company involved in developing oral and IV antibiotics of the next generation to treat infections caused by multidrug-resistant pathogens plunged -1.52% in yesterday’s normal trading session. The company has applied its New Drug Proposal (NDA) to the U.S.

Iterum Therapeutics plc (Nasdaq: ITRM) saw big hike in after-market with the news of New Drug Proposal to FDA Read More »